First Fiduciary Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.17M | Sell |
256,357
-11,852
| -4% | -$310K | 1.17% | 34 |
|
|
2026
Q1 | $7.53M | Sell |
268,209
-5,188
| -2% | -$138K | 1.51% | 32 |
|
|
2025
Q4 | $6.81M | Buy |
273,397
+41,665
| +18% | +$1.05M | 1.32% | 30 |
|
|
2025
Q3 | $5.91M | Sell |
231,732
-5,311
| -2% | -$131K | 1.15% | 32 |
|
|
2025
Q2 | $5.75M | Buy |
237,043
+4,928
| +2% | +$115K | 1.14% | 31 |
|
|
2025
Q1 | $5.88M | Buy |
232,115
+40,783
| +21% | +$1.07M | 1.26% | 33 |
|
|
2024
Q4 | $5.08M | Sell |
191,332
-43,670
| -19% | -$1.18M | 1.03% | 35 |
|
|
2024
Q3 | $6.8M | Sell |
235,002
-15,439
| -6% | -$450K | 1.36% | 31 |
|
|
2024
Q2 | $7.01M | Sell |
250,441
-1,570
| -0.6% | -$43.2K | 1.52% | 33 |
|
|
2024
Q1 | $6.99M | Sell |
252,011
-3,486
| -1% | -$96.7K | 1.45% | 34 |
|
|
2023
Q4 | $7.36M | Sell |
255,497
-10,323
| -4% | -$312K | 1.62% | 32 |
|
|
2023
Q3 | $8.82M | Buy |
265,820
+6,252
| +2% | +$221K | 2.07% | 25 |
|
|
2023
Q2 | $9.52M | Buy |
259,568
+41,816
| +19% | +$1.63M | 2.07% | 23 |
|
|
2023
Q1 | $8.88M | Buy |
217,752
+12,945
| +6% | +$559K | 1.97% | 26 |
|
|
2022
Q4 | $10.5M | Sell |
204,807
-2,797
| -1% | -$134K | 2.3% | 19 |
|
|
2022
Q3 | $9.09M | Sell |
207,604
-1,347
| -0.6% | -$65.5K | 2.28% | 21 |
|
|
2022
Q2 | $11M | Sell |
208,951
-3,099
| -1% | -$158K | 2.48% | 16 |
|
|
2022
Q1 | $11M | Sell |
212,050
-219,382
| -51% | -$11.4M | 2.14% | 20 |
|
|
2021
Q4 | $25.5M | Sell |
431,432
-28,327
| -6% | -$1.4M | 4.52% | 3 |
|
|
2021
Q3 | $19.8M | Sell |
459,759
-29,257
| -6% | -$1.3M | 3.86% | 7 |
|
|
2021
Q2 | $19.1M | Sell |
489,016
-44,032
| -8% | -$1.71M | 3.67% | 8 |
|
|
2021
Q1 | $19.3M | Sell |
533,048
-29,259
| -5% | -$1.04M | 3.68% | 10 |
|
|
2020
Q4 | $20.7M | Sell |
562,307
-35,552
| -6% | -$1.3M | 3.87% | 10 |
|
|
2020
Q3 | $20.8M | Sell |
597,859
-8,906
| -1% | -$312K | 4.33% | 6 |
|
|
2020
Q2 | $18.8M | Buy |
606,765
+1,118
| +0.2% | +$38K | 3.3% | 8 |
|
|
2020
Q1 | $18.8M | Sell |
605,647
-2,160
| -0.4% | -$73.6K | 4.97% | 4 |
|
|
2019
Q4 | $22.6M | Buy |
607,807
+50,401
| +9% | +$1.8M | 4.21% | 6 |
|
|
2019
Q3 | $19M | Buy |
557,406
+18,772
| +3% | +$683K | 4.02% | 6 |
|
|
2019
Q2 | $22.1M | Sell |
538,634
-68,743
| -11% | -$2.73M | 4.68% | 5 |
|
|
2019
Q1 | $24.5M | Sell |
607,377
-10,705
| -2% | -$429K | 4.53% | 4 |
|
|
2018
Q4 | $25.6M | Buy |
618,082
+895
| +0.1% | +$37.2K | 5.23% | 1 |
|
|
2018
Q3 | $25.8M | Sell |
617,187
-48,468
| -7% | -$1.87M | 4.82% | 2 |
|
|
2018
Q2 | $22.9M | Sell |
665,655
-11,215
| -2% | -$383K | 4.39% | 3 |
|
|
2018
Q1 | $22.8M | Buy |
676,870
+2,876
| +0.4% | +$98.9K | 4.53% | 3 |
|
|
2017
Q4 | $23.2M | Sell |
673,994
-19,641
| -3% | -$670K | 4.22% | 6 |
|
|
2017
Q3 | $23.5M | Buy |
693,635
+1,170
| +0.2% | +$37.6K | 4.3% | 6 |
|
|
2017
Q2 | $22.1M | Buy |
692,465
+8,463
| +1% | +$267K | 4.22% | 5 |
|
|
2017
Q1 | $22.2M | Sell |
684,002
-992
| -0.1% | -$31.3K | 4.3% | 7 |
|
|
2016
Q4 | $21.1M | Buy |
684,994
+60,926
| +10% | +$1.86M | 4.04% | 6 |
|
|
2016
Q3 | $20.1M | Buy |
624,068
+163,825
| +36% | +$5.48M | 4.23% | 6 |
|
|
2016
Q2 | $14.6M | Sell |
460,243
-9,827
| -2% | -$314K | 3.28% | 11 |
|
|
2016
Q1 | $13.2M | Buy |
470,070
+23,420
| +5% | +$669K | 2.9% | 19 |
|
|
2015
Q4 | $13.7M | Sell |
446,650
-5,703
| -1% | -$179K | 3.09% | 19 |
|
|
2015
Q3 | $13.5M | Sell |
452,353
-13,186
| -3% | -$423K | 3.24% | 12 |
|
|
2015
Q2 | $14.8M | Sell |
465,539
-4,142
| -0.9% | -$135K | 3.21% | 11 |
|
|
2015
Q1 | $15.5M | Buy |
469,681
+40,155
| +9% | +$1.28M | 3.34% | 11 |
|
|
2014
Q4 | $12.7M | Buy |
+429,526
| New | +$12.3M | 2.66% | 26 |
|
|
2014
Q2 | – | Sell |
-414,431
| Closed | -$12.6M | – | 45 |
|
|
2014
Q1 | $12.6M | Sell |
414,431
-11,758
| -3% | -$351K | 2.89% | 16 |
|
|
2013
Q4 | $12.4M | Sell |
426,189
-12,141
| -3% | -$353K | 2.88% | 20 |
|
|
2013
Q3 | $11.9M | Buy |
438,330
+6,491
| +2% | +$177K | 3.03% | 16 |
|
|
2013
Q2 | $11.5M | Buy |
+431,839
| New | +$11.9M | 3.01% | 14 |
|
Other funds holding PFE
First Fiduciary Investment Counsel's PFE Position: Q2 2026 in Review
First Fiduciary Investment Counsel reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $310K and leaving 256,357 shares worth $6.17M. The position accounts for 1.17% of the portfolio, ranked #34.
First Fiduciary Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $25.8M in Q3 2018. 1,762 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First Fiduciary Investment Counsel held 256,357 shares of Pfizer worth $6.17M as of Q2 2026.
- First Fiduciary Investment Counsel sold 11,852 Pfizer shares in Q2 2026, an estimated $310K.
- Pfizer made up 1.17% of First Fiduciary Investment Counsel's portfolio in Q2 2026, its #34 holding.
- First Fiduciary Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- First Fiduciary Investment Counsel's Pfizer position peaked at $25.8M in Q3 2018.
- 1,762 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First Fiduciary Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.